Catalyst Biosciences to Present at the Ladenburg Thalmann 2017 Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Sept. 22, 2017 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (Nasdaq: CBIO) today announced that Nassim Usman, Ph.D., President and Chief Executive Officer, will present a corporate overview at the Ladenburg Thalmann 2017 Healthcare Conference being held in New York City. The Catalyst Biosciences presentation will be held on Tuesday, September 26, 2017 at 3:30 p.m. Eastern Time.

About Catalyst  Catalyst is a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications. Catalyst is focused on the field of hemostasis, including the subcutaneous prophylaxis of hemophilia and facilitating surgery in individuals with hemophilia. For more information, please visit www.catalystbiosciences.com.

Contacts:

Investors:                                                                                
Fletcher Payne, CFO, Catalyst Biosciences                             
650.871.0761                                                                          
[email protected]

Media:
Denise Powell
510.703.9491
[email protected]

You May Also Be Interested In

• H.C. Wainwright Downgrades Crescent Biopharma Inc (CBIO) to Neutral
• Correct Pack to Showcase Coding and Marking Solutions at Propack Asia 2026
• Quantinuum Announces Pricing of Upsized Initial Public Offering